Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat

Brain Research

Volumn 624, Issue 1-2, 1993, Pages 126-130

  Lin, Jing Ying ^a   Mai, Lee Min ^a   Pan, Jenn Tser ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

6 Hydroxydopa; 6 Hydroxydopamine; Dopamine; HPLC; MPTP; Neurotoxin; Prolactin

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIHYDROXYPHENYLACETIC ACID; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; ARCUATE NUCLEUS; DIHYDROXYPHENYLALANINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; NEURONS; OXIDOPAMINE; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0027202561     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(93)90069-Y     Document Type: Article

References (40)

1. Time course of the effects of 6-hydroxydopamine on catecholamine-containing neurones in rat hypothalamus and striatum
2. Dopamine: a prolactin-inhibiting hormone
3. Regeneration of monoaminergic and cholinergic neurons in the mammalian central nervous system
4. Repeated administration ofN-methyl-4-phenyl-1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones
5. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons
6. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra byN-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
7. + on endogeneous dopamine release from the rat corpus striatum superfused in vitro
8. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
9. Neurochemical and behavioral effects of systemic and intranigral administration ofN-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat
10. Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary
11. Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA)
12. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus
13. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. I. The effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat
14. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice
15. Neurons with multiple messengers with special reference to neuroendocrine systems
16. Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain
17. Parkinsonism-inducing neurotoxin,N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain
18. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects
19. Chemical neurotoxins as denervation tools in neurobiology
20. Destructive action of systemically administered 6-hydroxydopamine on the rat area postrema
21. Neurotoxins that affect central and peripheral catecholamine neurons
22. Chronic parkinsonismin humans due to a product of meperidine analog synthesis
23. Dopamine receptor-mediated regulation of incertohypothalamic dopaminergic neurons in the male rat
24. Protein measurement with folin phenol reagent
25. Hypothalamic dopaminergic neurons
26. Excitotoxicity ofl-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's disease
27. The synthesis of 2,4,5-trihydroxyphenylalanine (6-hydroxydopa). A centrally active norepinephrine-depleting agent
28. Isolated removal of hypothalamic or other brain nuclei of the rat
29. Effects of internal carotid administration of MPTP on rat brain and blood-brain barrier
30. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver
31. + (1-methyl-4-phenylpyridinium) in three species: microdialysis of dopamine and metabolites in mouse, rat and monkey striatum
32. Development of the blood-brain barrier for 6-hydroxydopamine
33. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration
34. Effect of 6-hydroxydopamine lesions of the median eminence and neurointermediate lobe on the secretion of pituitary hormones in the male rat
35. Further studies on the effects in intravenously administered 6-hydroxydopamine on the median eminence of the rat
36. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine
37. Effects of 6-hydroxydopamine on catecholamine containing neurones in rat brain
38. Neuroendocrine aspects of circumventricular organs
39. 3H]MPTP binding sites in rat brain